Back to User profile » Dr Fangfang Xu

Papers published by Dr Fangfang Xu:

Original Research

Association Between Plasma Levels of ANGPTL3, 4, 8 and the Most Common Additional Cardiovascular Risk Factors in Patients with Hypertension

Xu F, Shen L, Yang Y, Kong L, Zu W, Tian D, Cao X, Huang G

Diabetes, Metabolic Syndrome and Obesity 2023, 16:1647-1655

Published Date: 7 June 2023

Original Research

ANGPTL8/Betatrophin Improves Glucose Tolerance in Older Mice and Metabolomic Analysis Reveals Its Role in Insulin Resistance in HepG2 Cells

Xu F, Wang N, Li G, Tian D, Shi X

Diabetes, Metabolic Syndrome and Obesity 2021, 14:4209-4221

Published Date: 11 October 2021

Original Research

Absolute Circulating Leukemic Cells as a Risk Factor for Early Bleeding Events in Patients with Non-High-Risk Acute Promyelocytic Leukemia

Pei Y, Shi M, Song J, Niu X, Wei S, Dou L, Xiao M, Li D, Xu F, Bai Y, Sun K

Cancer Management and Research 2021, 13:4135-4146

Published Date: 21 May 2021

Original Research

Prognostic Significance Of The Inflammatory Index-Based Scoring System In Patients Preliminarily Diagnosed With Multiple Myeloma In The Bortezomib-Based Chemotherapy Era

Liu S, Shi J, Guo H, Xu F, Wei M, Sun K, Chen Y

Cancer Management and Research 2019, 11:9409-9420

Published Date: 5 November 2019

Original Research

The synergistic antileukemic effects of eltrombopag and decitabine in myeloid leukemia cells

Shi M, Xu F, Yang X, Bai Y, Niu J, Drokow EK, Chen M, Chen Y, Sun K

Cancer Management and Research 2019, 11:8229-8238

Published Date: 6 September 2019